Recursion Pharmaceuticals has a flashy drug development platform. It has a lot to prove about whether that platform's use of AI is helpful. Some power players have backed it with significant ...
In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes through) become one company, combining Recursion’s expertise in biology with Exscientia’s focus on chemistry.
After hours: January 17 at 7:59:34 p.m. EST ...
NEW ugrep 7.1: a more powerful, ultra fast, user-friendly, compatible grep. Includes a TUI, Google-like Boolean search with AND/OR/NOT, fuzzy search, hexdumps ...
A monthly overview of things you need to know as an architect or aspiring architect.
A monthly overview of things you need to know as an architect or aspiring architect.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback